BE735439A - - Google Patents

Info

Publication number
BE735439A
BE735439A BE735439DA BE735439A BE 735439 A BE735439 A BE 735439A BE 735439D A BE735439D A BE 735439DA BE 735439 A BE735439 A BE 735439A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE735439A publication Critical patent/BE735439A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/80Oxygen atoms
    • C07D239/82Oxygen atoms with an aryl radical attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B27/00Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
    • G02B27/02Viewing or reading apparatus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE735439D 1968-07-01 1969-06-30 BE735439A (https=)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74180768A 1968-07-01 1968-07-01
US78725468A 1968-12-26 1968-12-26
US81943569A 1969-04-25 1969-04-25

Publications (1)

Publication Number Publication Date
BE735439A true BE735439A (https=) 1969-12-30

Family

ID=27419280

Family Applications (1)

Application Number Title Priority Date Filing Date
BE735439D BE735439A (https=) 1968-07-01 1969-06-30

Country Status (7)

Country Link
BE (1) BE735439A (https=)
CH (1) CH515911A (https=)
DE (1) DE1932396A1 (https=)
ES (6) ES368949A1 (https=)
FR (1) FR2012062A1 (https=)
GB (1) GB1256593A (https=)
NL (1) NL6909864A (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759671A (fr) * 1969-12-01 1971-06-01 Sandoz Sa Derives de la quinazolinone, leur preparation et medicaments contenant ces derives
DK129348B (da) * 1970-07-13 1974-09-30 Sumitomo Chemical Co Analogifremgangsmåde til fremstilling af 1-substituerede 3,4-dihydro-2(1H)-quinazolinonderivater.
DE2162327C3 (de) * 1970-12-23 1975-09-18 Sumitomo Chemical Co., Ltd., Osaka (Japan) Verfahren zur Herstellung von 3,4-Oihydro-2(1 H)-chinazolinonen
IL102764A0 (en) * 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
AU2436792A (en) * 1991-08-16 1993-03-16 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
ATE174908T1 (de) * 1993-05-26 1999-01-15 Sumitomo Pharma Chinazolinonderivate
WO2015120059A1 (en) * 2014-02-04 2015-08-13 Yates Charles Ryan Inhibitors of paxillin function and related compositions and methods

Also Published As

Publication number Publication date
FR2012062A1 (https=) 1970-03-13
NL6909864A (https=) 1970-01-05
ES388761A1 (es) 1974-03-01
GB1256593A (https=) 1971-12-08
ES368949A1 (es) 1971-07-16
ES388760A1 (es) 1974-03-01
ES388762A1 (es) 1974-03-01
CH515911A (de) 1971-11-30
DE1932396A1 (de) 1970-01-08
ES388758A1 (es) 1974-03-01
ES388759A1 (es) 1974-03-01

Similar Documents

Publication Publication Date Title
AU428130B2 (https=)
AU5184069A (https=)
AU6168869A (https=)
FR2012062A1 (https=)
FR2027023B1 (https=)
AU6171569A (https=)
AU416157B2 (https=)
AU429879B2 (https=)
AU4811568A (https=)
AU421558B1 (https=)
AU3224368A (https=)
AU3789668A (https=)
AU4744468A (https=)
BE726548A (https=)
AU463027A (https=)
BE727610A (https=)
AU479894A (https=)
BE728039A (https=)
BE727168A (https=)
AU479393A (https=)
BE726958A (https=)
BE723739A (https=)
BE726538A (https=)
BE728095A (https=)
BE726265A (https=)